We thought that our readers would appreciate the following, brief overview on personalized medicine and its market opportunity.
Many believe that personalized medicine (or genome-based medicine) is the future of healthcare—the next logical step as our knowledge of human genetics, disease, and wellness advances faster than ever before.
In addition to the promise of being more effective and efficient at treating patients, personalized medicine is of interest to many because of the market opportunity. According to the latest market research report by ReportsnReports.com, the personalized medicine market is expected to be worth over $149 billion by 2020, growing at a CAGR of 8.74%. This market is made up of companion diagnostics and targeted therapeutics and is dominated by oncology, cardiovascular and infectious disease treatment and diagnostics.